Menu
January 21, 2022
United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs
READ MOREOctober 18, 2021
United Therapeutics Provides an Update on the Progress of the Tyvaso DPI™ New Drug Application
READ MOREJune 3, 2021
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON Study of Tyvaso in Patients With Idiopathic Pulmonary Fibrosis
READ MORE